Pages that link to "Q39023214"
Jump to navigation
Jump to search
The following pages link to Streptococcus pneumoniae surface protein PcpA elicits protection against lung infection and fatal sepsis (Q39023214):
Displaying 50 items.
- Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New Antimicrobials (Q26744448) (← links)
- Nonencapsulated Streptococcus pneumoniae: Emergence and Pathogenesis (Q26752517) (← links)
- Diagnosis of pneumococcal pneumonia: current pitfalls and the way forward (Q26865184) (← links)
- The role of zinc in the interplay between pathogenic streptococci and their hosts (Q27003448) (← links)
- Genome analysis of a highly virulent serotype 1 strain of Streptococcus pneumoniae from West Africa (Q27315098) (← links)
- The host immune dynamics of pneumococcal colonization: implications for novel vaccine development (Q28084920) (← links)
- Virulence potential and genome-wide characterization of drug resistant Streptococcus pneumoniae clones selected in vivo by the 7-valent pneumococcal conjugate vaccine (Q28533656) (← links)
- Highly Variable Streptococcus oralis Strains Are Common among Viridans Streptococci Isolated from Primates (Q28834430) (← links)
- Intraclonal variations among Streptococcus pneumoniae isolates influence the likelihood of invasive disease in children (Q33585361) (← links)
- Panel 6: Vaccines (Q33644678) (← links)
- T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization (Q33820413) (← links)
- Streptococcus pneumoniae clonal complex 199: genetic diversity and tissue-specific virulence (Q33886611) (← links)
- Options for inactivation, adjuvant, and route of topical administration of a killed, unencapsulated pneumococcal whole-cell vaccine (Q33909187) (← links)
- Contributions to protection from Streptococcus pneumoniae infection using the monovalent recombinant protein vaccine candidates PcpA, PhtD, and PlyD1 in an infant murine model during challenge (Q34057765) (← links)
- Streptococcus pneumoniae in biofilms are unable to cause invasive disease due to altered virulence determinant production (Q34103322) (← links)
- PsrP, a protective pneumococcal antigen, is highly prevalent in children with pneumonia and is strongly associated with clonal type (Q34289805) (← links)
- Non-typeable pneumococci circulating in Portugal are of cps type NCC2 and have genomic features typical of encapsulated isolates (Q34355264) (← links)
- Prevalence and clonal distribution of pcpA, psrP and Pilus-1 among pediatric isolates of Streptococcus pneumoniae. (Q34358647) (← links)
- Preclinical Evaluation of the Pht Proteins as Potential Cross-Protective Pneumococcal Vaccine Antigens (Q34484575) (← links)
- Human antibodies to PhtD, PcpA, and Ply reduce adherence to human lung epithelial cells and murine nasopharyngeal colonization by Streptococcus pneumoniae (Q34595710) (← links)
- Identification of potential new protein vaccine candidates through pan-surfomic analysis of pneumococcal clinical isolates from adults. (Q34876231) (← links)
- Pathogenesis, treatment, and prevention of pneumococcal pneumonia (Q35010692) (← links)
- Evaluation of a vaccine formulation against Streptococcus pneumoniae based on choline-binding proteins (Q35021099) (← links)
- Next generation pneumococcal vaccines (Q35028495) (← links)
- Serum antibody response to five Streptococcus pneumoniae proteins during acute otitis media in otitis-prone and non-otitis-prone children (Q35811715) (← links)
- Genetic diversity of the Pneumococcal CbpA: Implications for next-generation vaccine development. (Q35886867) (← links)
- Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children (Q35887453) (← links)
- Higher levels of mucosal antibody to pneumococcal vaccine candidate proteins are associated with reduced acute otitis media caused by Streptococcus pneumoniae in young children (Q35915846) (← links)
- PspA family distribution, unlike capsular serotype, remains unaltered following introduction of the heptavalent pneumococcal conjugate vaccine (Q36017785) (← links)
- Transcriptional and metabolic effects of glucose on Streptococcus pneumoniae sugar metabolism (Q36128987) (← links)
- Immunization with Pneumococcal Surface Protein K of Nonencapsulated Streptococcus pneumoniae Provides Protection in a Mouse Model of Colonization (Q36211630) (← links)
- PcpA Promotes Higher Levels of Infection and Modulates Recruitment of Myeloid-Derived Suppressor Cells during Pneumococcal Pneumonia. (Q36600946) (← links)
- Antibody response to Streptococcus pneumoniae proteins PhtD, LytB, PcpA, PhtE and Ply after nasopharyngeal colonization and acute otitis media in children (Q36920037) (← links)
- Microbial interactions during upper respiratory tract infections (Q37028479) (← links)
- Next generation protein based Streptococcus pneumoniae vaccines (Q37130191) (← links)
- Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice (Q37145037) (← links)
- CD4+ T-cell responses among adults and young children in response to Streptococcus pneumoniae and Haemophilus influenzae vaccine candidate protein antigens (Q37184360) (← links)
- Asthma and antibodies to pneumococcal virulence proteins (Q37185085) (← links)
- Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide (Q37191236) (← links)
- CD4 T cell memory and antibody responses directed against the pneumococcal histidine triad proteins PhtD and PhtE following nasopharyngeal colonization and immunization and their role in protection against pneumococcal colonization in mice (Q37264678) (← links)
- Rationale and prospects for novel pneumococcal vaccines (Q37309218) (← links)
- A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge (Q37473239) (← links)
- Serotype-independent pneumococcal vaccines. (Q38069943) (← links)
- Current status and perspectives on protein-based pneumococcal vaccines (Q38124921) (← links)
- Immunization with LytB protein of Streptococcus pneumoniae activates complement-mediated phagocytosis and induces protection against pneumonia and sepsis (Q38795815) (← links)
- In vivo screen of genetically conserved Streptococcus pneumoniae proteins for protective immunogenicity (Q39212752) (← links)
- PcpA of Streptococcus pneumoniae mediates adherence to nasopharyngeal and lung epithelial cells and elicits functional antibodies in humans (Q39314657) (← links)
- Pneumonia and Streptococcus pneumoniae vaccine (Q39452604) (← links)
- The Spectrum of Invasive Pneumococcal Disease at an Adult Tertiary Care Hospital in the Early 21st Century (Q42912981) (← links)
- Influence of age, social patterns and nasopharyngeal carriage on antibodies to three conserved pneumococcal surface proteins (PhtD, PcpA and PrtA) in healthy young children (Q44240299) (← links)